Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for BioCryst Pharmaceuticals, Inc. (BCRX)

« Back to company index

BCRX Chatter Timeline

Stock Ticker for BCRX

Most Active Tweeters for BCRX

UserTweets
@Tickeron 7
@ez_scans 1
@dispatchtribune 1
@FaisamTrader 1
@OlympiaReport 1

Recent Tweets for BCRX

Gambiste1 @Gambiste1
RT @Tickeron: $BCRX in Downtrend: 50-day Moving Average moved below 200-day Moving Average on May 21, 2019. View odds for this and other in…
September 17th 2019, 6:09am
Tickeron @Tickeron
$BCRX in Downtrend: 50-day Moving Average moved below 200-day Moving Average on May 21, 2019. View odds for this an… https://t.co/nCmRwR6pmu
September 17th 2019, 3:09am
marketexclusive @marketexclusive
$BCRX BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Files An 8-K Entry into a Material Definitive Agreement https://t.co/So3Z5ZOinl
September 16th 2019, 2:09pm
MarketCurrents @MarketCurrents
$BCRX - BioCryst up 4% on extended timeline for debt financing https://t.co/o1PHsfLZ3T
September 16th 2019, 11:09am
fintel_io @fintel_io
$BCRX / BioCryst Pharmaceuticals files form 8-K - Entry into a Material Definitive Agreement https://t.co/96sZYDAyQv
September 16th 2019, 8:09am
Tickeron @Tickeron
$BCRX in Downtrend: 50-day Moving Average broke below 200-day Moving Average on May 21, 2019. View odds for this an… https://t.co/QiO1XUhX56
September 14th 2019, 5:09am
Tickeron @Tickeron
$BCRX's Aroon indicator reaches into Uptrend on September 4, 2019. View odds for this and other indicators:… https://t.co/yel9SByizH
September 12th 2019, 2:09am
StockNewsWires @StockNewsWires
$BCRX $MRK: KalVista: An Early Stage Company Doing Things The Right Way: https://t.co/O4sgWiaumV
September 11th 2019, 12:09pm
Tickeron @Tickeron
$BCRX in Downtrend: 50-day Moving Average moved below 200-day Moving Average on May 21, 2019. View odds for this an… https://t.co/SIjI6mGmPl
September 11th 2019, 2:09am
FaisamTrader @FaisamTrader
$bcrx we hit target 1 and 2...target 3 looks suuper easy..
September 10th 2019, 11:09pm
ez_scans @ez_scans
$BCRX (( u4_ubbb ))=upper bband breach
September 10th 2019, 3:09pm
ez_alertz @ez_alertz
$BCRX Triangle drugmaker looks to rebound with estimated $2 billion global market for new drug https://t.co/MbEIE8xXyv
September 10th 2019, 7:09am
Tickeron @Tickeron
$BCRX in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on May 21, 2019. View odds for this… https://t.co/8A8MQjHQuC
September 10th 2019, 2:09am
newswelldone @newswelldone
$BCRX $TAK: BioCryst Pharmaceuticals Inc. Represents Good Entry Opportunity …: https://t.co/sDAJOeBlyK
September 9th 2019, 9:09am
SeekingAlpha @SeekingAlpha
$BCRX - BioCryst Pharmaceuticals Inc. Represents Good Entry Opportunity At Current Prices https://t.co/coWDYUGT3Q
September 9th 2019, 8:09am
TickerReport @TickerReport
Critical Survey: Vericel $VCEL vs. BioCryst Pharmaceuticals $BCRX https://t.co/ZDrV0ZTKWw
September 9th 2019, 4:09am
Tickeron @Tickeron
$BCRX's Aroon indicator reaches into Uptrend on September 4, 2019. View odds for this and other indicators:… https://t.co/vfcEi6MmP9
September 9th 2019, 1:09am
OlympiaReport @OlympiaReport
Head to Head Comparison: Gilead Sciences $GILD vs. BioCryst Pharmaceuticals $BCRX https://t.co/v0CSuHxMBa
September 8th 2019, 6:09am
dispatchtribune @dispatchtribune
Contrasting Gilead Sciences $GILD & BioCryst Pharmaceuticals $BCRX https://t.co/xExB0bajMg
September 8th 2019, 6:09am
registrarjourn @registrarjourn
Head to Head Comparison: Gilead Sciences $GILD vs. BioCryst Pharmaceuticals $BCRX https://t.co/Aq2e0RvSnR
September 8th 2019, 6:09am
EnterpriseLeade @EnterpriseLeade
Head to Head Comparison: Gilead Sciences $GILD vs. BioCryst Pharmaceuticals $BCRX https://t.co/zit9AR7ASl
September 8th 2019, 6:09am
Tickeron @Tickeron
$BCRX in Downtrend: 50-day Moving Average broke below 200-day Moving Average on May 21, 2019. View odds for this an… https://t.co/9x1aVYJZ1x
September 8th 2019, 2:09am
dailypoliticaln @dailypoliticaln
BioCryst Pharmaceuticals $BCRX Shares Up 6.8% https://t.co/OYDlzYlu6a
September 7th 2019, 6:09pm
ThisLincolnian @ThisLincolnian
-$0.31 Earnings Per Share Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/qHbeIiHhv3
August 11th 2019, 11:08pm
WeekHerald @WeekHerald
$4.54 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/r59ZRzUcym
August 11th 2019, 11:08pm
stocknewstimes @stocknewstimes
Zacks Investment Research Lowers BioCryst Pharmaceuticals $BCRX to Sell https://t.co/97JLQ26iyn
August 11th 2019, 1:08pm
TranscriptDaily @TranscriptDaily
BioCryst Pharmaceuticals $BCRX Lowered to Sell at Zacks Investment Research https://t.co/U6KObzV0Wn
August 11th 2019, 1:08pm
AlecJones10 @AlecJones10
@juliaskripkaser Thanks for the notes here, quite helpful. What are the implications for $kalv given what we’ve seen with $bcrx so far?
August 11th 2019, 6:08am
dispatchtribune @dispatchtribune
BioCryst Pharmaceuticals $BCRX Downgraded by BidaskClub to Strong Sell https://t.co/SvnTd2noCM
August 11th 2019, 5:08am
TickerReport @TickerReport
BioCryst Pharmaceuticals $BCRX Downgraded by BidaskClub to Strong Sell https://t.co/hBpyGo0yfc
August 11th 2019, 5:08am
ConsumerFeed @ConsumerFeed
Analysts Set BioCryst Pharmaceuticals, Inc. $BCRX Price Target at $9.07 https://t.co/EWhGIZSVHm
August 10th 2019, 10:08pm
bbnsnews @bbnsnews
BioCryst Pharmaceuticals $BCRX Downgraded by BidaskClub https://t.co/zX93E8Ab8Q
August 10th 2019, 7:08pm
ThisLincolnian @ThisLincolnian
BioCryst Pharmaceuticals $BCRX Downgraded by BidaskClub https://t.co/BHiQKfdOEn
August 10th 2019, 7:08pm
macondailynews @macondailynews
BioCryst Pharmaceuticals $BCRX Shares Up 5.8% https://t.co/VUWhaoToMw
August 10th 2019, 4:08pm
TheMarketsDaily @TheMarketsDaily
BioCryst Pharmaceuticals $BCRX Trading Up 5.8% https://t.co/DcLbLx8mIn
August 10th 2019, 4:08pm
TickerReport @TickerReport
Q3 2019 EPS Estimates for BioCryst Pharmaceuticals, Inc. $BCRX Lowered by Piper Jaffray Companies https://t.co/YNvyskok31
August 10th 2019, 4:08am
ThisLincolnian @ThisLincolnian
Q3 2019 EPS Estimates for BioCryst Pharmaceuticals, Inc. $BCRX Lowered by Piper Jaffray Companies https://t.co/iFCRx4kWUD
August 10th 2019, 4:08am
WatchlistN @WatchlistN
BioCryst Pharmaceuticals $BCRX Rating Lowered to Sell at Zacks Investment Research https://t.co/igZMjn6CZx
August 9th 2019, 5:08pm
dailypoliticaln @dailypoliticaln
BioCryst Pharmaceuticals $BCRX Lowered to “Sell” at Zacks Investment Research https://t.co/fHpYcERTP1
August 9th 2019, 5:08pm
ConsumerFeed @ConsumerFeed
BioCryst Pharmaceuticals $BCRX Announces Earnings Results, Misses Estimates By $0.03 EPS https://t.co/CtUhxug5y8
August 9th 2019, 3:08pm
WeekHerald @WeekHerald
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Post Earnings of -$0.32 Per Share https://t.co/fwkfP74shr
August 9th 2019, 2:08pm
ThisLincolnian @ThisLincolnian
$4.54 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/V6H8XyLoiu
August 9th 2019, 2:08pm
bbnsnews @bbnsnews
$4.54 Million in Sales Expected for BioCryst Pharmaceuticals, Inc. $BCRX This Quarter https://t.co/BGlz8s6BcS
August 9th 2019, 2:08pm
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Announce Earnings of -$0.32 Per Share https://t.co/szKDPHY3z1
August 9th 2019, 2:08pm
dispatchtribune @dispatchtribune
BioCryst Pharmaceuticals, Inc. $BCRX Expected to Post Earnings of -$0.32 Per Share https://t.co/ng1kXKcoRU
August 9th 2019, 2:08pm
AmericanBanking @AmericanBanking
BioCryst Pharmaceuticals, Inc. Expected to Post FY2023 Earnings of $0.24 Per Share $BCRX https://t.co/eMDFyVpOJr #stocks
August 9th 2019, 12:08pm
dispatchtribune @dispatchtribune
Jefferies Financial Group Weighs in on BioCryst Pharmaceuticals, Inc.’s FY2023 Earnings $BCRX https://t.co/VLXTXZyAsw
August 9th 2019, 12:08pm
OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals, Inc. Expected to Post FY2023 Earnings of $0.24 Per Share $BCRX https://t.co/cJ9H8KA8Uo
August 9th 2019, 12:08pm
dailypoliticaln @dailypoliticaln
BioCryst Pharmaceuticals, Inc. $BCRX Receives Consensus Recommendation of “Hold” from Brokerages https://t.co/rPg70kC8fC
August 8th 2019, 7:08pm
WatchlistN @WatchlistN
BioCryst Pharmaceuticals, Inc. $BCRX Receives $9.07 Average Price Target from Brokerages https://t.co/3sMk8lWs60
August 8th 2019, 7:08pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.